Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-14

Clinical Trial Update: Randomized Control Trial of Sleeve Gastrectomy with Tirzepatide in Maximizing Weight Loss [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 randomized trial is investigating sleeve gastrectomy combined with tirzepatide (Mounjaro) to maximize weight loss in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MOUNJARO (tirzepatide)

Snippet

Sponsor: Nicholas Skertich | Conditions: Obesity and Obesity-related Medical Conditions | EARLY_Phase 1 | Status: RECRUITING